 Scott Oakes
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoplasmic Reticulum Stress | 11 | 2020 | 60 | 5.090 |
Why?
| | Endoplasmic Reticulum | 15 | 2017 | 235 | 3.990 |
Why?
| | Unfolded Protein Response | 8 | 2020 | 33 | 2.860 |
Why?
| | Mitochondria | 10 | 2015 | 485 | 1.970 |
Why?
| | Endoribonucleases | 7 | 2019 | 71 | 1.970 |
Why?
| | Apoptosis | 18 | 2015 | 1642 | 1.860 |
Why?
| | Protein-Serine-Threonine Kinases | 8 | 2019 | 521 | 1.520 |
Why?
| | Neoplasm Proteins | 3 | 2019 | 497 | 1.340 |
Why?
| | Pancreatic Neoplasms | 3 | 2019 | 670 | 1.250 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 7 | 2015 | 173 | 1.230 |
Why?
| | Protein Kinase Inhibitors | 6 | 2019 | 472 | 1.060 |
Why?
| | Caspase 2 | 2 | 2012 | 9 | 0.970 |
Why?
| | Embryonic Stem Cells | 3 | 2015 | 80 | 0.960 |
Why?
| | Homeostasis | 4 | 2017 | 370 | 0.930 |
Why?
| | Pancreatic Elastase | 1 | 2019 | 11 | 0.900 |
Why?
| | eIF-2 Kinase | 1 | 2019 | 46 | 0.880 |
Why?
| | Calcium | 6 | 2007 | 1195 | 0.840 |
Why?
| | Genetic Diseases, Inborn | 1 | 2019 | 94 | 0.840 |
Why?
| | Neuroendocrine Tumors | 1 | 2019 | 64 | 0.830 |
Why?
| | Pancreatitis | 1 | 2019 | 126 | 0.830 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 6 | 2010 | 13 | 0.780 |
Why?
| | bcl-2-Associated X Protein | 6 | 2010 | 45 | 0.770 |
Why?
| | Signal Transduction | 11 | 2019 | 3099 | 0.750 |
Why?
| | Proteostasis Deficiencies | 1 | 2016 | 3 | 0.750 |
Why?
| | Animals | 30 | 2020 | 25007 | 0.720 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2011 | 165 | 0.630 |
Why?
| | Neoplasms | 2 | 2020 | 2260 | 0.630 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 206 | 0.620 |
Why?
| | Adenocarcinoma | 2 | 2019 | 1174 | 0.600 |
Why?
| | Mice | 20 | 2019 | 10276 | 0.580 |
Why?
| | Motor Neurons | 2 | 2014 | 150 | 0.570 |
Why?
| | Amyotrophic Lateral Sclerosis | 2 | 2014 | 161 | 0.560 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 3 | 2011 | 15 | 0.560 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 217 | 0.560 |
Why?
| | Cysteine Endopeptidases | 1 | 2012 | 91 | 0.530 |
Why?
| | Oncogene Protein v-crk | 1 | 2011 | 1 | 0.530 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2011 | 45 | 0.520 |
Why?
| | MicroRNAs | 2 | 2014 | 449 | 0.510 |
Why?
| | Mutation | 6 | 2019 | 3462 | 0.510 |
Why?
| | Liver | 1 | 2017 | 1165 | 0.500 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2005 | 0.460 |
Why?
| | Cell Differentiation | 2 | 2015 | 1381 | 0.440 |
Why?
| | Proteins | 1 | 2015 | 733 | 0.440 |
Why?
| | Stress, Physiological | 1 | 2010 | 222 | 0.410 |
Why?
| | Humans | 31 | 2020 | 72293 | 0.370 |
Why?
| | Up-Regulation | 4 | 2019 | 657 | 0.350 |
Why?
| | Severe Combined Immunodeficiency | 4 | 1997 | 14 | 0.330 |
Why?
| | Membrane Proteins | 5 | 2014 | 1119 | 0.310 |
Why?
| | Models, Biological | 4 | 2016 | 1695 | 0.310 |
Why?
| | Cell Line, Tumor | 6 | 2019 | 2215 | 0.310 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 115 | 0.300 |
Why?
| | CDC2 Protein Kinase | 2 | 2015 | 40 | 0.300 |
Why?
| | Calcium Channels | 1 | 2004 | 197 | 0.280 |
Why?
| | Cells, Cultured | 10 | 2014 | 2829 | 0.280 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1444 | 0.270 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1173 | 0.260 |
Why?
| | HEK293 Cells | 3 | 2014 | 543 | 0.260 |
Why?
| | Fibroblasts | 3 | 2011 | 702 | 0.260 |
Why?
| | Protein-Tyrosine Kinases | 4 | 1997 | 284 | 0.250 |
Why?
| | Glioma | 3 | 2014 | 284 | 0.240 |
Why?
| | Interleukin-4 | 3 | 1997 | 117 | 0.240 |
Why?
| | Disease Models, Animal | 3 | 2019 | 2044 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 413 | 0.230 |
Why?
| | Adenine | 1 | 2019 | 53 | 0.220 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 6 | 0.200 |
Why?
| | B-Lymphocytes | 4 | 1997 | 726 | 0.200 |
Why?
| | Interleukin-2 | 3 | 1997 | 276 | 0.190 |
Why?
| | Indoles | 1 | 2019 | 293 | 0.190 |
Why?
| | Mice, Knockout | 3 | 2012 | 1802 | 0.190 |
Why?
| | Milk Proteins | 1 | 1996 | 24 | 0.180 |
Why?
| | Cell Survival | 1 | 2019 | 981 | 0.180 |
Why?
| | Enzyme Activation | 3 | 2014 | 718 | 0.170 |
Why?
| | Cell Line | 7 | 2015 | 2517 | 0.160 |
Why?
| | Students, Medical | 1 | 2019 | 281 | 0.160 |
Why?
| | Teratoma | 1 | 2015 | 38 | 0.160 |
Why?
| | RNA Stability | 2 | 2012 | 81 | 0.160 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 28 | 0.160 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2014 | 66 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 65 | 0.160 |
Why?
| | Immune Evasion | 1 | 2014 | 26 | 0.160 |
Why?
| | Neuromuscular Diseases | 1 | 2014 | 28 | 0.150 |
Why?
| | Phosphorylation | 5 | 2012 | 1105 | 0.150 |
Why?
| | Down-Regulation | 2 | 2012 | 486 | 0.150 |
Why?
| | Endosomes | 1 | 2014 | 72 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1119 | 0.150 |
Why?
| | Cell Line, Transformed | 2 | 2011 | 155 | 0.140 |
Why?
| | Golgi Apparatus | 1 | 2014 | 115 | 0.140 |
Why?
| | Superoxide Dismutase | 2 | 2014 | 178 | 0.140 |
Why?
| | Cell Proliferation | 1 | 2019 | 1451 | 0.140 |
Why?
| | Carrier Proteins | 3 | 2014 | 661 | 0.140 |
Why?
| | Brefeldin A | 1 | 2012 | 10 | 0.140 |
Why?
| | Cell-Free System | 1 | 2012 | 53 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 5 | 2014 | 352 | 0.140 |
Why?
| | Thioredoxins | 1 | 2012 | 14 | 0.140 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2012 | 23 | 0.140 |
Why?
| | Inflammasomes | 1 | 2012 | 12 | 0.140 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 86 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 344 | 0.130 |
Why?
| | Mutant Proteins | 1 | 2012 | 91 | 0.130 |
Why?
| | Cell Membrane | 2 | 2007 | 679 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 395 | 0.130 |
Why?
| | Cytochromes c | 1 | 2011 | 27 | 0.130 |
Why?
| | Glioblastoma | 1 | 2014 | 226 | 0.130 |
Why?
| | Herpesvirus 8, Human | 1 | 2011 | 18 | 0.130 |
Why?
| | Jurkat Cells | 1 | 2011 | 71 | 0.130 |
Why?
| | Purines | 1 | 2012 | 101 | 0.130 |
Why?
| | Caspases | 1 | 2011 | 164 | 0.120 |
Why?
| | Furans | 1 | 2010 | 14 | 0.120 |
Why?
| | Protein Unfolding | 1 | 2010 | 11 | 0.120 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 19 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 3 | 2003 | 639 | 0.120 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 362 | 0.120 |
Why?
| | Virus Replication | 1 | 2011 | 298 | 0.110 |
Why?
| | DNA-Binding Proteins | 3 | 2012 | 1127 | 0.110 |
Why?
| | Cell Death | 1 | 2010 | 252 | 0.110 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2010 | 156 | 0.110 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 752 | 0.110 |
Why?
| | Autophagy | 1 | 2010 | 124 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2014 | 728 | 0.100 |
Why?
| | Pyridines | 1 | 2010 | 278 | 0.100 |
Why?
| | Calcium-Transporting ATPases | 2 | 2004 | 28 | 0.100 |
Why?
| | Ribonucleases | 3 | 2014 | 87 | 0.100 |
Why?
| | Pyrimidines | 1 | 2010 | 320 | 0.100 |
Why?
| | Cytoprotection | 1 | 2007 | 45 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2012 | 2916 | 0.090 |
Why?
| | Immune System | 1 | 2007 | 75 | 0.090 |
Why?
| | Antigen-Presenting Cells | 1 | 2007 | 138 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2012 | 1916 | 0.090 |
Why?
| | Calcium Signaling | 2 | 2003 | 124 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2007 | 337 | 0.080 |
Why?
| | Janus Kinase 3 | 4 | 1997 | 9 | 0.080 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 17 | 0.080 |
Why?
| | Thapsigargin | 1 | 2004 | 53 | 0.080 |
Why?
| | Oxidative Stress | 2 | 2007 | 368 | 0.080 |
Why?
| | Phosphoproteins | 2 | 1996 | 246 | 0.080 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 93 | 0.080 |
Why?
| | Transcription Factors | 2 | 2012 | 1400 | 0.080 |
Why?
| | Trans-Activators | 2 | 1997 | 426 | 0.070 |
Why?
| | HeLa Cells | 1 | 2004 | 486 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 435 | 0.070 |
Why?
| | Sphingosine | 1 | 2003 | 77 | 0.070 |
Why?
| | Isoenzymes | 2 | 2014 | 271 | 0.070 |
Why?
| | Mitochondria, Liver | 1 | 2002 | 24 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2012 | 1023 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 2038 | 0.070 |
Why?
| | Cytochrome c Group | 1 | 2002 | 86 | 0.070 |
Why?
| | STAT6 Transcription Factor | 2 | 1997 | 18 | 0.060 |
Why?
| | Janus Kinase 1 | 2 | 1996 | 14 | 0.060 |
Why?
| | Imaging, Three-Dimensional | 1 | 2004 | 541 | 0.060 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 1996 | 55 | 0.060 |
Why?
| | San Francisco | 1 | 2019 | 13 | 0.050 |
Why?
| | Delphi Technique | 1 | 2019 | 52 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2012 | 684 | 0.050 |
Why?
| | Feedback | 1 | 2019 | 104 | 0.050 |
Why?
| | Female | 2 | 2019 | 39738 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2004 | 1129 | 0.050 |
Why?
| | Retinal Detachment | 1 | 2017 | 45 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2019 | 307 | 0.050 |
Why?
| | Receptors, IgE | 1 | 1996 | 9 | 0.050 |
Why?
| | Tomography, Optical Coherence | 1 | 2017 | 92 | 0.050 |
Why?
| | STAT5 Transcription Factor | 1 | 1996 | 40 | 0.050 |
Why?
| | Receptors, Interleukin-2 | 1 | 1996 | 71 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2017 | 293 | 0.050 |
Why?
| | Education, Medical, Undergraduate | 1 | 2019 | 129 | 0.050 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 29 | 0.040 |
Why?
| | Microscopy, Confocal | 2 | 2010 | 271 | 0.040 |
Why?
| | Tyrosine | 1 | 1995 | 136 | 0.040 |
Why?
| | Cyclin B2 | 1 | 2015 | 1 | 0.040 |
Why?
| | Cyclin B1 | 1 | 2015 | 16 | 0.040 |
Why?
| | Cyclin A | 1 | 2015 | 27 | 0.040 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2015 | 14 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 67 | 0.040 |
Why?
| | Interleukins | 1 | 1995 | 116 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2014 | 46 | 0.040 |
Why?
| | Rats | 2 | 2014 | 4151 | 0.040 |
Why?
| | Activating Transcription Factor 3 | 1 | 2014 | 4 | 0.040 |
Why?
| | Cholera Toxin | 1 | 2014 | 24 | 0.040 |
Why?
| | Choline O-Acetyltransferase | 1 | 2014 | 24 | 0.040 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2014 | 33 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2014 | 62 | 0.040 |
Why?
| | Blotting, Western | 2 | 2012 | 807 | 0.040 |
Why?
| | Myeloid Cells | 1 | 2014 | 70 | 0.040 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 59 | 0.040 |
Why?
| | Drug Resistance | 1 | 2015 | 254 | 0.040 |
Why?
| | RNA Interference | 1 | 2015 | 359 | 0.040 |
Why?
| | Monocytes | 1 | 2014 | 215 | 0.030 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2014 | 193 | 0.030 |
Why?
| | DNA Damage | 1 | 2015 | 335 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2012 | 94 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2012 | 89 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2012 | 64 | 0.030 |
Why?
| | Retina | 1 | 2014 | 189 | 0.030 |
Why?
| | Catalysis | 1 | 2012 | 197 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2435 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2014 | 284 | 0.030 |
Why?
| | Genes, Viral | 1 | 2011 | 124 | 0.030 |
Why?
| | RNA Splicing | 1 | 2012 | 119 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 228 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 260 | 0.030 |
Why?
| | DNA Primers | 1 | 2012 | 562 | 0.030 |
Why?
| | Chloroquine | 1 | 2010 | 13 | 0.030 |
Why?
| | Histological Techniques | 1 | 2010 | 31 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2014 | 357 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2014 | 512 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 508 | 0.030 |
Why?
| | Mice, Nude | 1 | 2012 | 756 | 0.030 |
Why?
| | Quinolines | 1 | 2010 | 85 | 0.030 |
Why?
| | Immunoblotting | 1 | 2010 | 278 | 0.030 |
Why?
| | Drug Synergism | 1 | 2010 | 319 | 0.030 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 110 | 0.030 |
Why?
| | Imidazoles | 1 | 2010 | 150 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 340 | 0.030 |
Why?
| | Cells | 1 | 2009 | 29 | 0.030 |
Why?
| | Multienzyme Complexes | 1 | 2009 | 68 | 0.030 |
Why?
| | Sirolimus | 1 | 2010 | 161 | 0.030 |
Why?
| | Protein Folding | 1 | 2009 | 283 | 0.020 |
Why?
| | Male | 4 | 2017 | 37354 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1724 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 1803 | 0.020 |
Why?
| | Insulin | 1 | 2009 | 1098 | 0.020 |
Why?
| | Ionomycin | 1 | 2003 | 29 | 0.020 |
Why?
| | Microscopy, Immunoelectron | 1 | 2003 | 36 | 0.020 |
Why?
| | Cell Fractionation | 1 | 2003 | 73 | 0.020 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 21 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2003 | 65 | 0.020 |
Why?
| | Histamine | 1 | 2003 | 131 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1990 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2003 | 158 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2002 | 13 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2002 | 116 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2002 | 513 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 554 | 0.010 |
Why?
| | Cyclosporine | 1 | 2002 | 242 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 22879 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 648 | 0.010 |
Why?
| | Consanguinity | 1 | 1996 | 72 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1996 | 86 | 0.010 |
Why?
| | Retroviridae | 1 | 1996 | 61 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1996 | 183 | 0.010 |
Why?
| | X Chromosome | 1 | 1996 | 163 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1996 | 654 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1996 | 420 | 0.010 |
Why?
| | Transfection | 1 | 1996 | 926 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1996 | 1029 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1996 | 740 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1997 | 3153 | 0.010 |
Why?
| | Child | 1 | 1996 | 5795 | 0.010 |
Why?
|
|
Oakes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|